Denise Burt Vanbrackle, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1000 Chastain Road, House 53, Kennesaw, GA 30144 Phone: 678-797-2018 |
News Archive
Sanofi and its subsidiary Genzyme announced today positive top-line results from CARE-MS I, the first of two randomized, Phase 3 clinical trials comparing the investigational drug alemtuzumab to the approved multiple sclerosis therapy Rebif in patients with relapsing-remitting multiple sclerosis.
Young patients with an aggressive form of leukemia who are likely to relapse after chemotherapy treatment can significantly reduce those odds by receiving additional courses of chemotherapy, suggest the findings of a clinical trial led by investigators at Dana-Farber/Children's Hospital Cancer Center in Boston.
Scientists at the Virginia Bioinformatics Institute at Virginia Tech have discovered some of the key molecular events in the immune system that contribute to inflammatory bowel disease. The results, which help researchers move one step further in their efforts to develop new drugs to treat inflammatory and immune-mediated diseases, are reported in the November 2010 edition of the journal Mucosal Immunology from the Nature Publishing Group.
Pittsburgh's Ohio Valley General Hospital, in an effort to improve patient safety, has implemented an automated system that uses barcoding and "smart" infusion system technology to ensure that patients receive the right intravenous (IV) medication at the appropriate dose and rate.
› Verified 3 days ago